Charting Thread, page-135

Another 52-week low. Ouch. Market must not be expecting a good H1 FY22 result?

The only indication of sales / outlook that I recall did seem to be pretty cautionary, with reference to volatility, “oversupply” of cheap PPE, and “customers experiencing business challenges”. They also note:
“Although we have seen improved monthly sales year to date FY22 as against Q4FY21, the business is subject to month to month volatility.
Further, it may take some time for more regular and predictable growth patterns to emerge given increasing infections in our major target markets and customer supply chain congestion.”

Personally I like their cash position vs MC, recent board refresh, and margins & earnings potential. Just waiting on the right time to increase holdings (change in sentiment?).